Literature DB >> 19220483

Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

M M Cox1, A M Tucker, J Tang, K Talbot, D C Richer, L Yeh, S E Arnold.   

Abstract

Sandy mice have a deletion mutation in the gene encoding dysbindin-1, Dtnbp1, with consequent reduction of the protein in heterozygotes and its loss in homozygotes. The sandy mouse thus serves as an animal model of dysbindin-1 function. As this protein is concentrated in synaptic tissue and affects transmitter release, it may affect neuronal processes that mediate behavior. To investigate the neurobehavioral effects of the Dtnbp1 mutation, we studied littermate sandy and wild-type controls on a C57BL/6J genetic background. The three animal groups were indistinguishable in their external physical characteristics, sensorimotor skills and indices of anxiety-like behaviors. In the open field, however, homozygous animals were hyperactive and appeared to show less habituation to the initially novel environment. In the Morris water maze, homozygous animals displayed clear deficits in spatial learning and memory with marginal deficits in visual association learning. Apart from the last mentioned deficits, these abnormalities are consistent with hippocampal dysfunction and in some cases with elevated dopaminergic transmission via D2 dopamine receptors. As similar deficits in spatial learning and memory have been found in schizophrenia, where decreased dysbindin-1 has been found in the hippocampus, the sandy mouse may also model certain aspects of cognition and behavior relevant to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220483      PMCID: PMC2774142          DOI: 10.1111/j.1601-183X.2009.00477.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  58 in total

1.  Extrinsic projections from area CA1 of the rat hippocampus: olfactory, cortical, subcortical, and bilateral hippocampal formation projections.

Authors:  T van Groen; J M Wyss
Journal:  J Comp Neurol       Date:  1990-12-15       Impact factor: 3.215

2.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

3.  Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.

Authors:  M A Benson; S E Newey; E Martin-Rendon; R Hawkes; D J Blake
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

Review 4.  Emergency management of agitation in schizophrenia.

Authors:  Catherine A Marco; Jason Vaughan
Journal:  Am J Emerg Med       Date:  2005-10       Impact factor: 2.469

Review 5.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

6.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  Sandy: a new mouse model for platelet storage pool deficiency.

Authors:  R T Swank; H O Sweet; M T Davisson; M Reddington; E K Novak
Journal:  Genet Res       Date:  1991-08       Impact factor: 1.588

8.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Cognitive impairments in the STOP null mouse model of schizophrenia.

Authors:  Kelly J Powell; Sarah E Hori; Ronald Leslie; Annie Andrieux; Heather Schellinck; Michael Thorne; George S Robertson
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

Review 10.  Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?

Authors:  Nigel M Williams; Michael C O'Donovan; Michael J Owen
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

View more
  56 in total

1.  Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.

Authors:  Erkang Fei; Xiaochuan Ma; Cuiqing Zhu; Ting Xue; Jie Yan; Yuxia Xu; Jiangning Zhou; Guanghui Wang
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Evodiamine improves congnitive abilities in SAMP8 and APP(swe)/PS1(ΔE9) transgenic mouse models of Alzheimer's disease.

Authors:  Shu-min Yuan; Kai Gao; Dong-mei Wang; Xiong-zhi Quan; Jiang-ning Liu; Chun-mei Ma; Chuan Qin; Lian-feng Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

Review 3.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 4.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

5.  The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.

Authors:  Ian J Orozco; Peter Koppensteiner; Ipe Ninan; Ottavio Arancio
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

6.  Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency.

Authors:  Verónica T Cheli; Richard W Daniels; Ruth Godoy; Diego J Hoyle; Vasundhara Kandachar; Marta Starcevic; Julian A Martinez-Agosto; Stephen Poole; Aaron DiAntonio; Vett K Lloyd; Henry C Chang; David E Krantz; Esteban C Dell'Angelica
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

Review 7.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 8.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

9.  Dysbindin promotes the post-endocytic sorting of G protein-coupled receptors to lysosomes.

Authors:  Aaron Marley; Mark von Zastrow
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

10.  The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.

Authors:  C A Ghiani; M Starcevic; I A Rodriguez-Fernandez; R Nazarian; V T Cheli; L N Chan; J S Malvar; J de Vellis; C Sabatti; E C Dell'Angelica
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.